Home > Products > CD55 & CA9 > Human Anti-CD55 x Anti-CA9 Bispecific Antibody (IgG-IgG)

Human Anti-CD55 x Anti-CA9 Bispecific Antibody (IgG-IgG)  (BSIG-H295)

Anti-CD55 x Anti-CA9 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD55 and anti-CA9 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can recruit complements to tumor cells. It is designed for the research of Renal cell cancer (RCC); Solid tumors therapy.

Specifications

Targets
CD55 & CA9
Type
IgG-IgG
Species Reactivity
Human
Target 1
CD55
Host Animal 1
Human
Target 2
CA9
Host Animal 2
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Renal cell cancer (RCC)Solid tumors

Targets

Target 1
CD55
Gene ID
UniProt ID
Alternative Names
CD55; CD55 molecule, decay accelerating factor for complement (Cromer blood group); CR; TC; DAF; CROM; complement decay-accelerating factor; CD55 antigen
Target 2
CA9
Gene ID
UniProt ID
Alternative Names
CA9; carbonic anhydrase 9; RCC-associated antigen G250; G250; CA-IX; carbonic anhydrase IX; MN; CAH9

Customer Reviews and Q&As

There are currently no customer reviews or questions for Human Anti-CD55 x Anti-CA9 Bispecific Antibody (IgG-IgG) (BSIG-H295). Click the button below to contact us or submit your feedback about this product.

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Welcome! For price inquiries, we will get back to you as soon as possible.

To order, please email

INQUIRY
Related products of "CD55 & CA9"
See other bsAb targets related to "CD55"

Online Inquiry

24x7 Service quality
USA

Tel:
Fax:
Email:

UK

Tel:
Email:

Germany

Tel:
Email: